European Medicines Agency Launches Pilot to Advance Alternatives to Animal Testing in Drug Development

The European Medicines Agency (EMA) has initiated a new voluntary data submission (VDS) pilot program to encourage the sharing of data generated using New Approach Methodologies (NAMs). These innovative methods aim to provide comparable or superior information to traditional animal testing, with the goal of reducing or replacing animal studies in non-clinical drug development. The pilot seeks to build regulatory confidence and experience with NAMs by allowing stakeholders to submit and discuss data with non-clinical experts, independent of a marketing authorization application.